Assessment of handling of inhaler devices in real life: an observational study in 3811 patients in primary care.

The correct use of inhalation devices is an inclusion criterion for all studies comparing inhaled treatments. In real life, however, patients may make many errors with their usual inhalation device, which may negate the benefits observed in clinical trials. Our study was undertaken to compare inhalation device handling in real life. A total of 3811 patients treated for at least 1 month with an inhalation device (Aerolizer, Autohaler, Diskus, pressurized metered dose inhaler (pMDI), or Turbuhaler) were included in this observational study performed in primary care in France between February 1st and July 14th, 2002. General practitioners had to assess patient handling of their usual inhaler device with the help of a checklist established for each inhaler model, from the package leaflet. Seventy-six percent of patients made at least one error with pMDI compared to 49-55% with breath-actuated inhalers. Errors compromising treatment efficacy were made by 11-12% of patients treated with Aerolizer, Autohaler, or Diskus compared to 28% and 32% of patients treated with pMDI and Turbuhaler, respectively. Overestimation of good inhalation by general practitioners was maximal for Turbuhaler (24%), and lowest for Autohaler and pMDI (6%). Ninety percent of general practitioners felt that participation in the study would improve error detection. These results suggest that there are differences in the handling of inhaler devices in real life in primary care that are not taken into account in controlled studies. There is a need for continued education of prescribers and users in the proper use of these devices to improve treatment efficacy.

[1]  M. Zureik,et al.  Misuse of pressurized metered dose inhalers by asthmatic patients treated in French private practice. , 1995, Revue d'epidemiologie et de sante publique.

[2]  N Roche,et al.  Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability , 2002, European Respiratory Journal.

[3]  T. Chinet,et al.  [Misuse of pressurized metered-dose aerosols in the treatment of bronchial diseases. Incidence and clinical consequences]. , 1994, Annales de medecine interne.

[4]  J Bousquet,et al.  Chronic respiratory diseases in developing countries: the burden and strategies for prevention and management. , 2001, Bulletin of the World Health Organization.

[5]  J. Lötvall,et al.  Equivalent therapeutic ratio of salbutamol given by Turbuhaler and Diskus. , 2000, Respiratory medicine.

[6]  N. Hanania,et al.  Medical Personnel's Knowledge of the Ability to Use Inhaling Devices , 1994 .

[7]  B. Meakin,et al.  Simulated ‘in-use’ and ‘mis-use’ aspects of the delivery of terbutaline sulphate from Bricanyl TurbohalerTM dry powder inhalers , 1995 .

[8]  N. Hanania,et al.  Medical personnel's knowledge of and ability to use inhaling devices. Metered-dose inhalers, spacing chambers, and breath-actuated dry powder inhalers. , 1994, Chest.

[9]  V. Plaza,et al.  Patient perception and acceptability of multidose dry powder inhalers: a randomized crossover comparison of Diskus/Accuhaler with Turbuhaler. , 2002, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[10]  李幼升,et al.  Ph , 1989 .

[11]  J. J. Klein,et al.  Evaluation of the effectiveness of four different inhalers in patients with chronic obstructive pulmonary disease. , 1995, Thorax.

[12]  S. Clarke,et al.  Improvement of drug delivery with a breath actuated pressurised aerosol for patients with poor inhaler technique. , 1991, Thorax.

[13]  J. Lötvall,et al.  Similar bronchodilation with formoterol delivered by aerolizer or turbuhaler. , 1999, Canadian respiratory journal.

[14]  J. Lötvall,et al.  Equivalent bronchodilation with salbutamol given via pMDI or turbuhaler. , 1999, American journal of respiratory and critical care medicine.